4.7 Article

Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)

Journal

ANNALS OF ONCOLOGY
Volume 23, Issue 11, Pages 2964-2970

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mds140

Keywords

case-control studies; pancreatitis; pancreatic cancer; pooled analysis; risk factors

Categories

Funding

  1. National Cancer Institute (NCI)
  2. Prevention, Control and Population Research Goldstein Award
  3. society of MSKCC
  4. Geoffrey Beene Cancer Research Fund
  5. National Institutes of Health [5R01CA098870, CA59706, CA108370, CA109767, CA89726, CA121846]
  6. Stamford Hospital
  7. National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics
  8. Rombauer Pancreatic Cancer Research Fund
  9. California Department of Public Health
  10. National Cancer Institute's Surveillance, Epidemiology, and End Results Program [N01-PC-35136]
  11. Centers for Disease Control and Prevention's National Program of Cancer Registries [U55/CCR921930-02]
  12. Italian Association for Cancer Research (AIRC) [10068]
  13. Ministry of Health, Welfare, and Sports (formerly Ministry of Welfare, Health, and Culture) of the Netherlands
  14. Commission of the European Communities
  15. Fonds de recerche du Quebec - Sante (FRSQ)
  16. U.S. National Institutes of Health [CA98380]
  17. CD Smithers Foundation
  18. Spanish Ministry of Health [ISCIII RETICC RD06/0020]

Ask authors/readers for more resources

Pancreatitis is a known risk factor for pancreatic cancer; however, an unknown fraction of the disease is thought to be a consequence of tumor-related duct obstruction. A pooled analysis of a history of pancreatitis and risk of pancreatic cancer was carried out considering the time interval between diagnoses and potential modification by covariates. Adjusted pooled odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from 10 case-control studies (5048 cases of ductal pancreatic adenocarcinoma and 10 947 controls) taking part in the International Pancreatic Cancer Case-Control Consortium (PanC4). The association between pancreatitis and pancreatic cancer was nearly three-fold at intervals of > 2 years between diagnoses (OR: 2.71, 95% CI: 1.96-3.74) and much stronger at intervals of < 2 years (OR: 13.56, 95% CI: 8.72-21.90) probably reflecting a combination of reverse causation and antecedent misdiagnosis of pancreas cancer as pancreatitis. The younger (< 65 years) pancreatic cancer cases showed stronger associations with previous (> 2 years) pancreatitis (OR: 3.91, 95% CI: 2.53-6.04) than the older (>= 65 years) cases (OR: 1.68, 95% CI: 1.02-2.76; P value for interaction: 0.006). Despite a moderately strong association between pancreatitis (diagnosed before > 2 years) and pancreatic cancer, the population attributable fraction was estimated at 1.34% (95% CI: 0.612-2.07%), suggesting that a relatively small proportion of pancreatic cancer might be avoided if pancreatitis could be prevented.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available